![Michael GONZALEZ | Professor (Full) | DSc, NMD, PhD, FANMA, FACN | University of Puerto Rico, Medical Sciences Campus, San Juan | Department of Human Development | Research profile Michael GONZALEZ | Professor (Full) | DSc, NMD, PhD, FANMA, FACN | University of Puerto Rico, Medical Sciences Campus, San Juan | Department of Human Development | Research profile](https://i1.rgstatic.net/ii/profile.image/1001884793991170-1615879357772_Q512/Michael-Gonzalez-24.jpg)
Michael GONZALEZ | Professor (Full) | DSc, NMD, PhD, FANMA, FACN | University of Puerto Rico, Medical Sciences Campus, San Juan | Department of Human Development | Research profile
Nanotechnology-Abetted Astaxanthin Formulations in Multimodel Therapeutic and Biomedical Applications | Journal of Medicinal Chemistry
![Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in](https://www.ahajournals.org/cms/asset/eab7d797-1589-4839-acaa-71c8caa14f38/15ff2.jpg)
Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in
![How can physical health be better addressed in people living with severe mental illnesses? | ResearchGate How can physical health be better addressed in people living with severe mental illnesses? | ResearchGate](https://i1.rgstatic.net/ii/profile.image/375942640881665-1466643118917_Q512/Hannah-Kirkwood-2.jpg)
How can physical health be better addressed in people living with severe mental illnesses? | ResearchGate
![Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in](https://www.ahajournals.org/cms/asset/08339483-5351-49f4-9caf-45ba5014d108/15ff1b.jpg)